DOCSLIB.ORG

Fungal Endophthalmitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

............................ Mycosis of the Eye and Its Adnexa .. ............................ Developments in Ophthalmology Vol. 32 Series Editor W. Behrens-Baumann, Magdeburg ............................ Mycosis of the Eye and Its Adnexa W. Behrens-Baumann, Magdeburg with a contribution by R. RuÈchel,GoÈttingen 39 ®gures, 31 in color, and 39 tables, 1999 ............................ Prof. Dr. med. W. Behrens-Baumann Klinik fuÈr Augenheilkunde, Otto-von-Guericke-UniversitaÈt Leipziger Strasse 44, D±39120 Magdeburg This is a revised and extended translation of a former German version entitled Pilzerkrankungen des Auges by Wolfgang Behrens-Baumann The reproduction of the color illustrations in this book was made possible by a generous contribution from the Heinz Karger Memorial Foundation Continuation of `Bibliotheca Ophthalmologica', `Advances in Ophthalmology', and `Modern Problems in Ophthalmology' Founded 1926 as `Abhandlungen aus der Augenheilkunde und ihren Grenzgebieten' by C. Behr, Hamburg and J. Meller, Wien Former Editors: A. BruÈckner, Basel (1938±1959); H. J. M. Wewe, Utrecht (1938±1962); H. M. Dekking, Groningen (1954±1966); E. R. StreiV, Lausanne (1954±1979); J. FrancËois, Gand (1959±1979); J. van Doesschate, Utrecht (1967±1971); M. J. Roper-Hall, Birmingham (1966±1980); H. Sautter, Hamburg (1966±1980); W. Straub, Marburg a. d. Lahn (1981±1993) Library of Congress Cataloging-in-Publication Data Behrens-Baumann, Wolfgang. [Pilzerkrankungen des Auges, English] Mycosis of the eye and its adnexa / W. Behrens-Baumann; with a contribution by R. Ruchel. (Developments in ophthalmology; vol. 32) Includes bibliographical references and indexes. 1. Oculomycoses. I. Ruchel, R. II. Title. III. Series. [DNLM: 1. Eye Infections, Fungal ± drug therapy. 2. Eye Infections, Fungal ± diagnosis. W1 DE998NG v.32 1999] RE901.F8B4413 1999 617.7 ± dc21 ISSN 0250±3751 ISBN 3±8055±6915±7 (hardcover : alk. paper) Bibliographic Indices. This publication is listed in bibliographic services, including Current ContentsÔ and Index Medicus. Drug Dosage. The authors and the publisher have exerted every eVort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant ¯ow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Ó Copyright 1999 by S. Karger AG, P.O. Box, CH±4009 Basel (Switzerland) www.karger.com Printed in Switzerland on acid-free paper by Reinhardt Druck, Basel ISBN 3±8055±6915±7 ............................ Contents 1 1 An Overview of Fungal Pathogens of Ophthalmological Importance R. RuÈchel,GoÈttingen 1 1.1 Introduction 2 1.2 Zygomycota 4 1.3 Ascomycota 5 1.4 Basidiomycota 6 1.5 Deuteromycota 8 1.6 Indigenous Fungi Causing Invasive Mycoses 8 1.6.1 Candida albicans 11 1.6.2 Candida tropicalis 12 1.6.3 Candida parapsilosis 12 1.6.4 Candida glabrata (Torulopsis glabrata) and C. krusei 13 1.6.5 Rare Agents of Invasive Yeast Infections 13 1.6.6 Mixed Infections 13 1.6.7 Cryptococcus neoformans 15 1.6.8 Aspergillus fumigatus 17 1.6.9 Mucormycosis 19 1.6.10 Fusariomycosis 19 1.6.11 Scedosporium spp. 19 1.6.12 Histoplasmosis 20 1.7 Causative Agents of Super®cial Mycosis 21 1.8 Miscellaneous 21 1.8.1 Actinomycetales 22 1.8.2 Collection of Specimens and Culturing of Fungi 23 References 25 Glossary V 27 2 Antifungal Agents 27 2.1 Polyenes 27 2.1.1 Amphotericin B 30 2.1.2 Natamycin (Pimaricin) 30 2.1.3 Nystatin 31 2.2 Flucytosine 32 2.3 Azoles 32 2.3.1 Clotrimazole 33 2.3.2 Miconazole 34 2.3.3 Ketoconazole 35 2.3.4 Itraconazole 36 2.3.5 Fluconazole 37 2.3.6 Econazole, Voriconazole and Other Azole Antifungal Agents 37 2.3.6.1 Econazole 38 2.3.6.2 Voriconazole 38 2.3.6.3 Saperconazole and Thiabendazole 39 2.4 Miscellaneous Antifungal Agents 40 2.5 Recommended Drugs for Fungal Infections 41 References 52 3 Periocular Fungal Infections 52 3.1 Palpebral Involvement 52 3.2 Infections of the Lacrimal Ducts 54 3.3 Fungal Infections of the Orbit 56 3.3.1 Mucormycosis 58 3.3.1.1 Case Report 59 3.3.2 Aspergillus and Other Fungal Organisms 62 References 68 4 Mycoses of the Anterior Segment of the Eye 68 4.1 Prevalence of Fungi in the Conjunctival Flora 70 4.2 Fungal Conjunctivitis 70 4.3 Fungal Scleritis 71 4.4 Keratomycosis 73 4.4.1 Predisposing Factors 73 4.4.1.1 Corticosteroids 74 4.4.1.2 Antibiotics 75 4.4.1.3 Foreign Bodies 75 4.4.1.4 Postoperative Keratomycosis 76 4.4.1.5 Pre-Existing Eye Diseases 76 4.4.1.6 Contact Lenses Contents VI 77 4.4.1.7 Systemic Illness 77 4.4.1.8 Age, Sex, Climate and Season 78 4.4.2 Spectrum of Pathogens Causing Keratomycosis 78 4.4.3 Clinical Aspects of Keratomycoses 84 4.4.4 Further Diagnostic Measures in Keratomycosis 87 4.4.5 Histopathology of the Keratomycoses 88 4.4.6 Treatment of Keratomycosis 88 4.4.6.1 Medical Treatment 88 4.4.6.1.1 Antifungal Agents 89 4.4.6.1.2 Antifungal Agents Plus Corticosteroids 90 4.4.6.2 Surgical Treatment 92 4.4.7 Case Histories 92 4.4.7.1 Case 1 92 4.4.7.2 Case 2 94 4.4.7.3 Case 3 94 4.4.7.4 Case 4 94 4.4.7.5 Case 5 94 References 108 5 Fungal Endophthalmitis 108 5.1 Pathogenesis and Clinical Features 108 5.1.1 Endogenous Fungal Endophthalmitis 108 5.1.1.1 Pathogens 108 5.1.1.2 Causes 112 5.1.1.3 Clinical Features 116 5.1.1.3.1 Endogenous Aspergillus Endophthalmitis 117 5.1.1.3.2 Endogenous Cryptococcus Endophthalmitis 118 5.1.2 Exogenous Fungal Endophthalmitis 118 5.1.2.1 Causes 118 5.1.2.1.1 Postoperative Fungal Endophthalmitis 122 5.1.2.1.2 Fungal Endophthalmitis following Injury 122 5.1.2.1.3 Fungal Endophthalmitis following Keratomycosis or Scleritis 122 5.1.2.2 Clinical Features and Diagnosis 123 5.2 Treatment of Fungal Endophthalmitis 123 5.2.1 Drug Treatment 123 5.2.1.1 Local Antimycotic Therapy 124 5.2.1.2 Systemic Antimycotic Therapy 126 5.2.1.3 Surgical Treatment 129 References Contents VII 144 6 Histoplasmosis 144 6.1 Systemic Histoplasmosis 144 6.1.1 Epidemiology and Clinical Features 145 6.1.2 Diagnosis 145 6.1.2.1 Histoplasmin Skin Testing 146 6.1.2.2 Other Tests 147 6.2 Ocular Histoplasmosis 152 6.3 Treatment of Histoplasmosis 152 6.3.1 Treatment of Systemic Histoplasmosis 152 6.3.2 Treatment of Ocular Histoplasmosis 152 6.3.2.1 Drug Treatment 153 6.3.2.2 Photocoagulation and Surgical Treatment 154 6.4 DiVerential Diagnosis of Ocular Histoplasmosis 155 References 162 7 Experimental Findings in the Eye 162 7.1 Experimental Models of Keratomycosis 162 7.1.1 Development of DiVerent Models of Infection with Live Pathogens 162 7.1.1.1 Inoculation Technique and Immunosuppression 163 7.1.1.2 Strains Used for Infection 168 7.1.1.3 Antibiotics and Bacterial Superinfection 169 7.1.1.4 Immune Status of Experimental Animals 169 7.1.2 Keratomycosis Models Using Fungal Extracts 169 7.1.3 A Reproducible Model of Keratomycosis 171 7.2 Bioavailability of Antimycotic Agents 172 7.2.1 Amphotericin B 173 7.2.2 Bifonazole and Clotrimazole 173 7.2.3 Natamycin (Primaricin) 173 7.2.4 Fluconazole 174 7.2.5 Miconazole, Ketoconazole and Itraconazole 175 7.3 Experimental Toxicity of Antimycotic Agents 175 7.3.1 Corneal Toxicity 175 7.3.2 Retinal Toxicity 175 7.4 Treatment of Experimental Keratomycosis 175 7.4.1 Timing of Treatment 175 7.4.2 EVect of Antimycotic Agents on Experimental Keratomycosis 177 7.4.2.1 Amphotericin B 179 7.4.2.2 Bifonazole and Clotrimazole 179 7.4.2.3 Natamycin (Pimaricin) 179 7.4.2.4 Ketoconazole, Miconazole and Fluconazole 181 7.4.2.5 Miscellaneous Agents 181 7.4.3 Corticosteroids in the Treatment of Experimental Keratomycosis with Antimycotic Agents Contents VIII 182 7.4.4 Operative Treatment of Experimental Keratomycosis 183 7.5 Experimental Fungal Endophthalmitis 183 7.5.1 Experimental Endogenous Fungal Endophthalmitis 183 7.5.1.1 Experimental Models 185 7.5.1.2 Therapeutic Studies in the Endogenous Endophthalmitis Model 186 7.5.2 Experimental Exogenous Fungal Endophthalmitis 187 7.6 Experimental Histoplasmosis 189 References 197 Subject Index Contents IX OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Dedicated to my wife Cordula and our daughters Verena and Corinna Chapter 1 ............................ An Overview of Fungal Pathogens of Ophthalmological Importance R. RuÈchel 1.1 Introduction Fungi were initially thought to be plants that lacked chlorophyll, but following the proposal of Whittaker [1], they are now considered to be an independent ®fth kingdom of life in parallel with the Monera (bacteria and certain prokaryotic algae), Protoctista (protozoa, nucleated algae, slime moulds, etc.), Plantae and Animalia. Fungi (mycetes) are eukaryotes, in con- trast to the bacteria (prokaryotes).
Recommended publications
  • Congo DRC, Kamwiziku. Mycoses 2021

    Congo DRC, Kamwiziku. Mycoses 2021

    Received: 8 April 2021 | Revised: 1 June 2021 | Accepted: 10 June 2021 DOI: 10.1111/myc.13339 REVIEW ARTICLE Serious fungal diseases in Democratic Republic of Congo – Incidence and prevalence estimates Guyguy K. Kamwiziku1 | Jean- Claude C. Makangara1 | Emma Orefuwa2 | David W. Denning2,3 1Department of Microbiology, Kinshasa University Hospital, University of Abstract Kinshasa, Kinshasa, Democratic Republic A literature review was conducted to assess the burden of serious fungal infections of Congo 2Global Action Fund for Fungal Infections, in the Democratic Republic of the Congo (DRC) (population 95,326,000). English and Geneva, Switzerland French publications were listed and analysed using PubMed/Medline, Google Scholar 3 Manchester Fungal Infection Group, The and the African Journals database. Publication dates spanning 1943– 2020 were in- University of Manchester, Manchester Academic Health Science Centre, cluded in the scope of the review. From the analysis of published articles, we estimate Manchester, UK a total of about 5,177,000 people (5.4%) suffer from serious fungal infections in the Correspondence DRC annually. The incidence of cryptococcal meningitis, Pneumocystis jirovecii pneu- Guyguy K. Kamwiziku, Department monia in adults and invasive aspergillosis in AIDS patients was estimated at 6168, of Microbiology, Kinshasa University Hospital, University of Kinshasa, Congo. 2800 and 380 cases per year. Oral and oesophageal candidiasis represent 50,470 Email: [email protected] and 28,800 HIV- infected patients respectively. Chronic pulmonary aspergillosis post- tuberculosis incidence and prevalence was estimated to be 54,700. Fungal asthma (allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitiza- tion) probably has a prevalence of 88,800 and 117,200.
  • Financial Supporters

    Financial Supporters

    FINANCIAL SUPPORTERS Care and Share Food Bank for Southern Colorado 2011-12 Financial Supporters 100% Chiropractic Lanny and Paul Adams Mr. and Mrs. Jeffrey Ahrendsen 14K Real Estate Investments LLC Ms. Laura Adams Mr. Kevin Ahrens 1882 Management Mr. and Mrs. Lon Adams Mr. and Mrs. Charles Aiken 1st Cavalry Rocky Mountain Chapter Col and Mrs. Louis Adams Ms. Laverne Ainley 221 South Oak Bistro Ms. Maggie Adams Air Academy Federal Credit Union 4-Bits 4-H Club Ms. Mary Adams Air Academy Federal Credit Union 4Clicks - Solutions, LLC Mr. Michael Adams Air Academy High School - District 20 A & L Aluminum Manufacturing Company Mr. and Mrs. Rexford Adams Mr. TJ Airhart A Handymike Home Repair Mr. and Mrs. Robert Adams Aka Wilson, LLC A to Z Realty Mr. S. Michael Adams Mr. Richard Alaniz AA “Accurate and Affordable” Striping, Inc. Mr. and Mrs. Samuel Adams Ms. Susan Alarid AAA NCNU Insurance Exchange Mr. Steve Adams Ms. Karin Alaska AAA Northern California Nevada & Utah Suzanne Adams Mr. Arturo Albanesi AARP Foundation Adams Bank & Trust Mr. and Mrs. Mac Alberico Ms. Renee Abbe Mrs. Alda Adcox Ms. Cheryl Alberto Ms. Marjory Abbott Add Staff Inc. Mr. and Mrs. Dewey Albertson Jr. Mr. and Mrs. Peyton Abbott Ms. Constance Addington Mr. W. Gary Albertson Ms. Stephanie Abbott Mr. and Mrs. D. V. Addington Albertsons LLC Ms. Brianna Abby Ms. Linda Addington Mr. and Mrs. Albert Albrandt Mr. and Mrs. Donald Abdallah Ms. Vicky Addison Mr. Gerald Albrecht Mr. Tony Abdella Ms. Deirdre Aden-Smith Ms. Patricia Albright Mr. and Mrs. William Abel Mr.
  • 70-2294 ALY, Raza, 1935- IMMÜNOLOGICAL RESPONSE OF

    70-2294 ALY, Raza, 1935- IMMÜNOLOGICAL RESPONSE OF

    This dissertation has been microfilmed exactly as received 70-2294 ALY, Raza, 1935- IMMÜNOLOGICAL RESPONSE OF GUINEA PIGS CHRONICALLY INFECTED WITH REPEATED AND A SINGLE DOSE OF HISTOPLASMA DUBOISII. The University of Oklahoma, Ph.D., 1969 Microbiology University Microfilms, Inc., Ann Arbor, Michigan THE UNIVERSITY OF OKLAHOMA GRADUATE COLLEGE IMMUNOLOGICAL RESPONSE OF GUINEA PIGS CHRONICALLY INFECTED WITH REPEATED AND A SINGLE DOSE OF HISTOPLASMA DUBOISII A DISSERTATION SUBMITTED TO THE GRADUATE FACULTY in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY BY RAZA ALY Norman, Oklahoma 1969 IMMUNOLOGICAL RESPONSE OF GUINEA PIGS CHRONICALLY INFECTED WITH REPEATED AND A SINGLE DOSE OF HISTOPLASMA DUBOISII APPROVED BY DISSERTATION COMMITTEE ACKNOWLEDGEMENT The author wishes to express his sincere thanks to Dr. Howard W. Larsh for his inspiration and continued guidance throughout this study. A special note of thanks to Dr. G. C. Cozad, Dr. J. H, Lancaster I Dr. D. 0. Cox, and Dr. L. S. Ciereszko for their assistance in the writing of this manuscript. Sincere appréciation to Dr. Peter A. Bartels for his assis­ tance. A special note of appreciation is also extended to Miss Janis Reeser, Miss Mary Jane Hook, and Mr. Don Wiggins for their technical assistance in this study. Also, a special note of appreciation to my wife Naheed for editing and typing the manuscript. Ill TABLE OF CONTENTS Page LIST OF TABLES ............... » . v LIST OF ILLUSTRATIONS . .............. vi Chapter I. INTRODUCTION .......... ............ 1 II. MATERIALS AND METHODS ........... .. 8 III. RESULTS ............. 22 IV. DISCUSSION ........... 42 V. SUMMARY AND CONCLUSIONS........... 48 BIBLIOGRAPHY ............. 5© IV LIST OF TABLES Table Page 1.
  • Acute Disseminated Histoplasmosis of Pulmonary Origin Probably Contracted in Britain by A

    Acute Disseminated Histoplasmosis of Pulmonary Origin Probably Contracted in Britain by A

    Thorax: first published as 10.1136/thx.16.4.388 on 1 December 1961. Downloaded from Thorax (1961), 16, 388. ACUTE DISSEMINATED HISTOPLASMOSIS OF PULMONARY ORIGIN PROBABLY CONTRACTED IN BRITAIN BY A. A. MILLER, F. RAMSDEN, AND M. R. GEAKE From the Group Laboratory, Preston Royal Infirmary, and Sharoe Green Hospital, Preston (RECEIVED FOR PUBLICATION NOVEMBER 28, 1960) Histoplasmosis in any form is an unusual made a comprehensive study of the varied radio- finding in Great Britain. The case described in logical appearances in 28 cases of histoplasmosis; this paper is that of a man with bilateral of these cases nine showed pulmonary involve- pulmonary histoplasmosis which terminated with ment. Furcolow (1960) indicates that at least 30% an acute disseminated infection. It is believed to of positive skin test reactors have, or develop, be an example of an indigenous British infection. demonstrable lesions. Symmers (1956) made a critical analysis of the 15 cases of histoplasmosis reported in Great INDIGENOUS INFECTIONS Britain up to 1956 and found two of them The first unequivocal, mycologically proved (Limerick, 1951) unacceptable as there was instance of histoplasmosis in which the infection insufficient evidence to warrant the diagnosis of was contracted in Britain is believed to be that copyright. histoplasmosis. Earle, Highman, and Lockley reported by Symmers (1956) and was a case of (1960) described a fatal case of acute disseminated histoplasmic lymphadenitis. histoplasmosis in a man aged 62 years who had In the case described here the patient had never lived in India for 30 years and contracted the been outside Great Britain except during the disease in that country.

  • Monograph on Dimorphic Fungi

    Monograph on Dimorphic Fungi A guide for classification, isolation and identification of dimorphic fungi, diseases caused by them, diagnosis and treatment By Mohamed Refai and Heidy Abo El-Yazid Department of Microbiology, Faculty of Veterinary Medicine, Cairo University 2014 1 Preface When I see the analytics made by academia.edu for the visitors to my publication has reached 244 in 46 countries in one month only, this encouraged me to continue writing documents for the benefit of scientists and students in the 5 continents. In the last year I uploaded 3 monographs, namely 1. Monograph on yeasts, Refai, M, Abou-Elyazeed, H. and El-Hariri, M. 2. Monograph on dermatophytes, Refai, M, Abou-Elyazeed, H. and El-Hariri, M. 3. Monograph on mycotoxigenic fungi and mycotoxins, Refai, M. and Hassan, A. Today I am uploading the the 4th documents in the series of monographs Monograph on dimorphic fungi, Refai, M. and Abou-Elyazeed, H. Prof. Dr. Mohamed Refai, 2.3.2014 Country 30 day views Egypt 51 2 Country 30 day views Ethiopia 22 the United States 21 Saudi Arabia 19 Iraq 19 Sudan 14 Uganda 12 India 11 Nigeria 9 Kuwait 8 the Islamic Republic of Iran 7 Brazil 7 Germany 6 Uruguay 4 the United Republic of Tanzania 4 ? 4 Libya 4 Jordan 4 Pakistan 3 the United Kingdom 3 Algeria 3 the United Arab Emirates 3 South Africa 2 Turkey 2 3 Country 30 day views the Philippines 2 the Netherlands 2 Sri Lanka 2 Lebanon 2 Trinidad and Tobago 1 Thailand 1 Sweden 1 Poland 1 Peru 1 Malaysia 1 Myanmar 1 Morocco 1 Lithuania 1 Jamaica 1 Italy 1 Hong Kong 1 Finland 1 China 1 Canada 1 Botswana 1 Belgium 1 Australia 1 Argentina 4 1.
  • Septic Arthritis Due to Histoplasma Capsulatum in a Leukaemic Patient

    Septic Arthritis Due to Histoplasma Capsulatum in a Leukaemic Patient

    Ann Rheum Dis: first published as 10.1136/ard.44.2.128 on 1 February 1985. Downloaded from Annals of the Rheumatic Diseases, 1985, 44, 128-129 Case report Septic arthritis due to Histoplasma capsulatum in a leukaemic patient PAULA G JONES,' KENNETH ROLSTON,' AND ROY L HOPFER2 From the Section of 'Infectious Diseases, Department of Internal Medicine and 2Department of Laboratory Medicine, the University of Texas M.D. Anderson Hospital and Tumor Institute at Houston, 6723 Bertner Avenue, Houston, Texas 77030, USA SUMMARY A case of septic, histoplasmal monoarthritis of the knee in a leukaemic patient is described. Ketoconazole therapy failed to eliminate the infection, but after histoplasmosis was diagnosed prolonged therapy with amphotericin B was curative. Key words: fungi, histoplasmosis, leukaemia, myeloproliferative disorders, antifungal agents. copyright. A 29-year-old man with acute myelogenous ramycin, and trimethoprim-sulphamethoxazole, the leukaemia refractory to chemotherapy was admitted patient was given amphotericin B empirically, re- to the hospital with fever, diarrhoea, and neut- sulting in prompt defervescence. A total dose of 180 ropenia on 23 September 1983. On physical ex- mg of pamphotericin B was given over five days. amination the patient's temperature was 38-5°C. His Broad-spectrum antibiotics were given for 22 days pulse was 120/min, blood pressure, 150/60 mmHg, because of the possibility of bacterial infection. http://ard.bmj.com/ and respiratory rate 18/min. He had severe mucosi- Chest roentgenograms during this period showed an tis of the oropharynx. There were no other signifi- infiltrate in the lower left lung. The patient was cant physical findings.
  • ADAPTATION of FORESTS and PEOPLE to CLIMATE Change – a Global Assessment Report

    ADAPTATION of FORESTS and PEOPLE to CLIMATE Change – a Global Assessment Report

    International Union of Forest Research Organizations Union Internationale des Instituts de Recherches Forestières Internationaler Verband Forstlicher Forschungsanstalten Unión Internacional de Organizaciones de Investigación Forestal IUFRO World Series Vol. 22 ADAPTATION OF FORESTS AND PEOPLE TO CLIMATE CHANGE – A Global Assessment Report Prepared by the Global Forest Expert Panel on Adaptation of Forests to Climate Change Editors: Risto Seppälä, Panel Chair Alexander Buck, GFEP Coordinator Pia Katila, Content Editor This publication has received funding from the Ministry for Foreign Affairs of Finland, the Swedish International Development Cooperation Agency, the United Kingdom´s Department for International Development, the German Federal Ministry for Economic Cooperation and Development, the Swiss Agency for Development and Cooperation, and the United States Forest Service. The views expressed within this publication do not necessarily reflect official policy of the governments represented by these institutions. Publisher: International Union of Forest Research Organizations (IUFRO) Recommended catalogue entry: Risto Seppälä, Alexander Buck and Pia Katila. (eds.). 2009. Adaptation of Forests and People to Climate Change. A Global Assessment Report. IUFRO World Series Volume 22. Helsinki. 224 p. ISBN 978-3-901347-80-1 ISSN 1016-3263 Published by: International Union of Forest Research Organizations (IUFRO) Available from: IUFRO Headquarters Secretariat c/o Mariabrunn (BFW) Hauptstrasse 7 1140 Vienna Austria Tel: + 43-1-8770151 Fax: + 43-1-8770151-50 E-mail: [email protected] Web site: www.iufro.org/ Cover photographs: Matti Nummelin, John Parrotta and Erkki Oksanen Printed in Finland by Esa-Print Oy, Tampere, 2009 Preface his book is the first product of the Collabora- written so that they can be read independently from Ttive Partnership on Forests’ Global Forest Expert each other.
  • Diagnosis of Histoplasmosis

    Diagnosis of Histoplasmosis

    Brazilian Journal of Microbiology (2006) 37:1-13 ISSN 1517-8382 DIAGNOSIS OF HISTOPLASMOSIS Allan Jefferson Guimarães1,2; Joshua D. Nosanchuk2; Rosely Maria Zancopé-Oliveira1* 1Serviço de Micologia, Departamento de Micro-Imuno-Parasitologia, Instituto de Pesquisa Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil; 2Department of Medicine (Division of Infectious Diseases) & Microbiology and Imunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York Submitted: January 31, 2006; Approved: February 13, 2006 ABSTRACT Endemic mycoses can be challenging to diagnose and accurate interpretation of laboratory data is important to ensure the most appropriate treatment for the patients. Although the definitive diagnosis of histoplasmosis (HP), one of the most frequent endemic mycoses in the world, is achieved by direct diagnosis performed by micro and/or macroscopic observation of Histoplasma capsulatum (H. capsulatum), serologic evidence of this fungal infection is important since the isolation of the etiologic agents is time-consuming and insensitive. A variety of immunoassays have been used to detect specific antibodies to H. capsulatum. The most applied technique for antibody detection is immunodiffusion with sensitivity between 70 to 100 % and specificity of 100%, depending on the clinical form. The complement fixation (CF) test, a methodology extensively used on the past, is less specific (60 to 90%). Detecting fungal antigens by immunoassays is valuable in immunocompromised individuals where such assays achieve positive predictive values of 96-98%. Most current tests in diagnostic laboratories still utilize unpurified antigenic complexes from either whole fungal cells or their culture filtrates. Emphasis has shifted, however, to clinical immunoassays using highly purified and well-characterized antigens including recombinant antigens.
  • Buscapronta Base De Dados Junho/2010

    Buscapronta Base De Dados Junho/2010

    BUSCAPRONTA WWW.BUSCAPRONTA.COM BASE DE DADOS JUNHO/2010 9.264.260 SOBRENOMES / ENDEREÇOS PESQUISADOS SITES E LINKS A 145147 B 1347538 C 495817 D 276690 E 17216 F 177217 G 105102 H 61772 I 4082 J 29600 K 655085 L 42311 M 550085 N 540620 O 4793 P 117441 Q 226 R 1716485 S 1089982 T 71176 U 35625 V 47393 W 1681776 X / Y 1490 Z 49591 ATUALIZAÇÕES E PÁGINAS OFF LINE PODEM ALTERAR (PARA MAIS OU PARA MENOS) OS PRESENTES NÚMEROS EM ATÉ 5% A 8% ATENÇÃO Os números apresentados à direita de alguns sobrenomes indicam o número de sites e links correspondentes. Links podem se referir a um ou mais indivíduos. Sobrenomes sem numeração à direita se referem a famílias, indivíduo ou grupo de indivíduos. Relação de sobrenomes apresentada em 3 segmentos distintos (um não substitui o outro quando apresentar o mesmo sobrenome). Eventualmente, poderá ocorrer superposição de informação sobre um mesmo indivíduo, em endereços Internet diferentes. Este arquivo geral não substitui os demais arquivos apresentados no site BUSCAPRONTA. Para facilitar sua pesquisa utilize a ferramenta EDITAR/LOCALIZAR so WORD. BUSCAPRONTA não reproduz dados genealógicos. È necessário acessar os sites e links correspondentes. As informações contidas nos sites e links são de única e exclusiva responsabilidade de seus respectivos editores. O Banco de Dados do BUSCAPRONTA é complementado diariamente com novos dados eventualmente não apresentados neste resumo geral. Se você não encontrou aqui todos os dados de que necessita para sua pesquisa entre em contato e informe sobre os sobrenomes
  • Luciano Polonelli

    Luciano Polonelli

    Luciano Polonelli Department of Biomedical, Biotechnological and Translational Sciences, Unit of Microbiology and Virology, University of Parma, Parma, Italy Tel.: +39 0521 903429; Fax: +39 0521 993620; e-mail: [email protected] History of Medical Mycology File 2 (1895-1950) 1895 Giuseppe Marconi (1862-1940), born in Naples, Italy, Professor of Veterinary Pathology and Clinic in the Royal University of Pisa, Italy, isolated and cultivated for the first time Cryptococcus farciminosum, the agent of epizootic lymphangitis, in the form of sterile mycelium (1895). Piero Redaelli and Raffaele Ciferri transferred (1934) C. farciminosum to the genus Histoplasma, as H. farciminosum (Rivolta and Micellone 1883, Redaelli and Ciferri 1934), mainly because of its dimorphic nature that made it similar to the tissue form of H. capsulatum var. capsulatum Darling 1906. Robert J. Weeks, Arvind A. Padhye and Libero Ajello, at the Division of Mycotic Diseases, Center for Infectious Diseases, Centers for Disease Control (C.D.C.) Atlanta, Georgia, U.S.A. (1985), observed that this fungus generated macro- and microconidia resembling those of the capsulatum and duboisii varieties of H. capsulatum when incubated at room temperature, thus reducing the fungus to a varietal status as H. capsulatum var. farciminosum (Rivolta, 1873) Weeks, Padhye & Ajello, 1985. Raffaele Ciferri (1960) reduced Histoplasma duboisii (Vanbreuseghem, 1992) to varietal status as H. capsulatum var. duboisii (Vanbreuseghem, 1992), Ciferri, 1960 [Ajello, 1998; Marcone, 1895; Redaelli and Ciferri, 1934; Weeks et al., 1985]. 1 1896 The American surgeon Emmet Rixford (1865-1938), born in Bedford, Canada, first graduated in engineering and then Doctor in Medicine (1891), and Thomas C.
  • WO 2013/038197 Al 21 March 2013 (21.03.2013) P O P C T

    WO 2013/038197 Al 21 March 2013 (21.03.2013) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/038197 Al 21 March 2013 (21.03.2013) P O P C T (51) International Patent Classification: Geir [NO/NO]; Bj0rndalen 81, N-7072 Heimdal (NO). A01N 43/16 (2006.01) A01N 43/653 (2006.01) MYRVOLD, Rolf [NO/NO]; 0vre Gjellum vei 28, N- A61K 31/734 (2006.01) A01P 3/00 (2006.01) 1389 Heggedal (NO). A01N 43/90 (2006.01) (74) Agent: DEHNS; St Bride's House, 10 Salisbury Square, (21) International Application Number: London EC4Y 8JD (GB). PCT/GB20 12/052274 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date kind of national protection available): AE, AG, AL, AM, 14 September 2012 (14.09.2012) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (25) English Filing Language: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (26) Publication Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (30) Priority Data: ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 1116010.8 15 September 201 1 (15.09.201 1) GB NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (71) Applicant (for all designated States except US): AL- RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, GIPHARMA AS [NO/NO]; Industriveien 33, N-1337 TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, Sandvika (NO).
  • Astronautics and Aeronautics, 1966

    Astronautics and Aeronautics, 1966

    NASA SP-4007 ASTRONAUTICS AND AERONAUTICS, 1966 Chronology on Science, Technology, and Policy Text by Science and Technology Division Library of Congress Sponsored by NASA Historical Staff Office of Policy Screntrfic and Technrcal Information Divisron 1967 NATIONAL AERONAUTICS AND SPACE ADMINISTRATION WaJhington, D.C. For Sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402 Price 8.50 (paper cover) Library of Congrcss Catalog Card Nmbcr 66-60096 Foreword . .. At the opening of the tenth year in the era of man’s mobility in outer space, we can look back on 1966 as offering convincing evidence that the United States had gained great competence. This evidence included: five orbital space flights by ten Gemini astronauts; four lunar missions under- taking the orbiting of and softlanding on the moon; numerous contributions to scientific knowledge by unmanned spacecraft and sounding rockets; and further demonstrations of the practical utility of operational space systems, including weather and communications satellites. During 1966, a record 100 American spacecraft were placed into earth orbit or on escape trajectories. Thousands of revealing and useful pictures of the earth were taken from space and of the moon from lunar orbit and on its surface. The Gemini program ended with rendezvous and docking experiments and extravehicular activity by the Gemini test pilots as the Apollo R&D test flights leading to the manned lunar mission came into the schedule. Thirty-five major scientific, technological, and operational mile- stones were cited for 1966 by the President in his Report to the Congress on aeronautical and space activities of the United States.